{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T23:21:42Z","timestamp":1768260102301,"version":"3.49.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":5509,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,8]]},"DOI":"10.1046\/j.1365-2133.2000.03667.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T05:29:37Z","timestamp":1047360577000},"page":"385-391","source":"Crossref","is-referenced-by-count":129,"title":["Treatment of atopic eczema with oral mycophenolate mofetil"],"prefix":"10.1093","volume":"143","author":[{"given":"K.","family":"Neuber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Itschert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.tom","family":"Dieck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"10.1046\/j.1365-2133.2000.03667.x-BIB1","doi-asserted-by":"crossref","first-page":"484","DOI":"10.2340\/0001555571484487","article-title":"The influence of interferon-gamma and interleukin-4 on IgE production in B lymphocytes of patients with atopic eczema","volume":"71","author":"Gruner","year":"1990","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"10.1046\/j.1365-2133.2000.03667.x-BIB2","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0091-6749(05)80010-7","article-title":"Decreased interferon gamma and increased interleukin-4 production in atopic dermatitis promotes IgE synthesis","volume":"90","author":"Jujo","year":"1992","journal-title":"J Allergy Clin Immunol"},{"key":"10.1046\/j.1365-2133.2000.03667.x-BIB3","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1084\/jem.172.2.463","article-title":"Structure and expression of germline \u03b5-transcripts in human B-cells induced by interleukin 4 to switch to IgE production","volume":"172","author":"Gauchat","year":"1990","journal-title":"J Exp Med"},{"key":"10.1046\/j.1365-2133.2000.03667.x-BIB4","doi-asserted-by":"crossref","first-page":"5576","DOI":"10.4049\/jimmunol.150.12.5576","article-title":"Th2 cells mediate IL-4 dependent local tissue inflammation","volume":"150","author":"Muller","year":"1993","journal-title":"J Immunol"},{"key":"10.1046\/j.1365-2133.2000.03667.x-BIB5","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1073\/pnas.90.8.3730","article-title":"Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells","volume":"90","author":"Punnonen","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.1365-2133.2000.03667.x-BIB6","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/eji.1830200203","article-title":"Regulation of human IgE synthesis. I. Human IgE synthesis in vitro is determined by reciprocal antagonistic effects of IL-4 and IFN\u03b3","volume":"20","author":"Chretien","year":"1990","journal-title":"Eur J Immunol"},{"key":"10.1046\/j.1365-2133.2000.03667.x-BIB7","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/0190-9622(93)70152-J","article-title":"Systemic interferon gamma treatment in severe atopic dermatitis","volume":"29","author":"Reinhold","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1046\/j.1365-2133.2000.03667.x-BIB8","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/00000658-199210000-00014","article-title":"RS-61443 (mycophenolate mofetil). A multicenter study for refractory kidney transplant rejection","volume":"216","author":"Sollinger","year":"1992","journal-title":"Ann Surg"},{"key":"10.1046\/j.1365-2133.2000.03667.x-BIB9","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0190-9622(97)70147-6","article-title":"Rediscovering mycophenolic acid: a review of its mechanism, side effects, and potential uses","volume":"37","author":"Silverman Kitchin","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1046\/j.1365-2133.2000.03667.x-BIB10","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/1523-1747.ep12610346","article-title":"Treatment of psoriasis\u00a0with oral mycophenolic acid","volume":"65","author":"Jones","year":"1975","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1365-2133.2000.03667.x-BIB11","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1365-2133.1978.tb06537.x","article-title":"Mycophenolic acid in psoriasis","volume":"98","author":"Spatz","year":"1978","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.1365-2133.2000.03667.x-BIB12","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0190-9622(87)70285-0","article-title":"Mycophenolic acid for psoriasis","volume":"17","author":"Epinette","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1046\/j.1365-2133.2000.03667.x-BIB13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-3083.1991.tb03746.x","article-title":"Lymphocyte-selective cytostatic and immunosuppressive effects of mycophenolic acid in vitro: role of deoxyguanosine nucleotide depletion","volume":"33","author":"Eugui","year":"1991","journal-title":"Scand J Immunol"},{"key":"10.1046\/j.1365-2133.2000.03667.x-BIB14","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-3083.1991.tb03747.x","article-title":"Lymphocyte-selective antiproliferative and immunosuppressive effects of mycophenolic acid in mice","volume":"33","author":"Eugui","year":"1991","journal-title":"Scand J Immunol"},{"issue":"Suppl.","key":"10.1046\/j.1365-2133.2000.03667.x-BIB15","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2340\/00015555924447","article-title":"Diagnostic features of atopic dermatitis","volume":"5","author":"Hanifin","year":"1980","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"10.1046\/j.1365-2133.2000.03667.x-BIB16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000247298","article-title":"Severity Scoring of Atopic Dermatitis: the SCORAD index","volume":"186","author":"European Task Force on Atopic Dermatitis.","year":"1993","journal-title":"Dermatology"},{"key":"10.1046\/j.1365-2133.2000.03667.x-BIB17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000236970","article-title":"Staphylococcal enterotoxin B affects in vitro IgE synthesis, interferon-\u03b3, interleukin-4 and interleukin-5 production in atopic eczema","volume":"107","author":"Neuber","year":"1995","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1046\/j.1365-2133.2000.03667.x-BIB18","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/bimj.4710330208","article-title":"A simple testing procedure versus k treatments for one-sided ordered alternatives, with application in toxicology","volume":"33","author":"Hothorn","year":"1997","journal-title":"Biometr J"},{"key":"10.1046\/j.1365-2133.2000.03667.x-BIB19","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1365-2133.1994.tb13111.x","article-title":"Cyclosporin in atopic dermatitis: a multicentre placebo-controlled study","volume":"130","author":"van Joost","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.1365-2133.2000.03667.x-BIB20","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0140-6736(05)63084-X","article-title":"Treatment of pemphigus vulgaris with mycophenolate mofetil. (Letter.)","volume":"350","author":"Enk","year":"1997","journal-title":"Lancet"},{"key":"10.1046\/j.1365-2133.2000.03667.x-BIB21","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0140-6736(97)80092-X","article-title":"Bullous pemphigoid treated with mycophenolate mofetil. (Letter.)","volume":"349","author":"B\u00f6hm","year":"1997","journal-title":"Lancet"},{"key":"10.1046\/j.1365-2133.2000.03667.x-BIB22","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1046\/j.1365-3083.1997.d01-438.x","article-title":"Circulating T cells of patients with active psoriasis respond to\u00a0streptococcal M-peptides sharing sequences with human epidermal keratins","volume":"45","author":"Sigmundsdottir","year":"1997","journal-title":"Scand J Immunol"},{"key":"10.1046\/j.1365-2133.2000.03667.x-BIB23","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/1523-1747.ep12329617","article-title":"Immunoglobulin E response to human proteins in atopic patients","volume":"107","author":"Valenta","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1365-2133.2000.03667.x-BIB24","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0091-6749(98)70270-2","article-title":"Topical tacrolimus (FK506): a new milestone in the management of atopic dermatitis","volume":"102","author":"Bieber","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1046\/j.1365-2133.2000.03667.x-BIB25","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/00015559850135814","article-title":"Long-term follow-up of eczema patients treated with cyclosporine","volume":"78","author":"Hakan","year":"1998","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"10.1046\/j.1365-2133.2000.03667.x-BIB26","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2133.1997.tb08750.x","article-title":"Long-term efficacy and safety of cyclosporin in severe adult atopic dermatitis","volume":"136","author":"Berth-Jones","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.1365-2133.2000.03667.x-BIB27","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/0190-9622(90)70353-J","article-title":"Management of patients and side-effects during cyclosporine therapy for cutaneous disorders","volume":"23","author":"Fradin","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1046\/j.1365-2133.2000.03667.x-BIB28","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00007890-198701000-00008","article-title":"Cancers following cyclosporine therapy","volume":"43","author":"Penn","year":"1987","journal-title":"Transplantation"},{"key":"10.1046\/j.1365-2133.2000.03667.x-BIB29","first-page":"307","volume-title":"Cyclosporin A","author":"Bird","year":"1982"},{"key":"10.1046\/j.1365-2133.2000.03667.x-BIB30","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev.iy.11.040193.001121","article-title":"Interleukin-10","volume":"11","author":"Moore","year":"1993","journal-title":"Annu Rev Immunol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2133.2000.03667.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1046\/j.1365-2133.2000.03667.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T13:23:25Z","timestamp":1704288205000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/143\/2\/385\/6688281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,8]]}},"URL":"https:\/\/doi.org\/10.1046\/j.1365-2133.2000.03667.x","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,8]]}}}